Canada markets closed

EyeGene Inc. (185490.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Add to watchlist
2,900.00-25.00 (-0.85%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.73
52-Week Change 3-34.12%
S&P500 52-Week Change 324.78%
52 Week High 34,895.00
52 Week Low 30.00
50-Day Moving Average 33,149.40
200-Day Moving Average 33,341.32

Share Statistics

Avg Vol (3 month) 371.84k
Avg Vol (10 day) 355.26k
Shares Outstanding 510.99M
Implied Shares Outstanding 6N/A
Float 819.38M
% Held by Insiders 128.02%
% Held by Institutions 10.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21.2:1
Last Split Date 3Jun 28, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-682.82%

Management Effectiveness

Return on Assets (ttm)-19.30%
Return on Equity (ttm)-29.61%

Income Statement

Revenue (ttm)2.87B
Revenue Per Share (ttm)124.80
Quarterly Revenue Growth (yoy)-32.70%
Gross Profit (ttm)N/A
EBITDA -20.1B
Net Income Avi to Common (ttm)-16.61B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)45.72B
Total Cash Per Share (mrq)1,697.93
Total Debt (mrq)3.21B
Total Debt/Equity (mrq)5.41%
Current Ratio (mrq)8.53
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-20.07B
Levered Free Cash Flow (ttm)-13.3B